Bioethics FDA Presentation Public Health 
Bill of Health
APRIL 24, 2023
Yet Dmitry Karshtedt held otherwise at the ASLME Health Law Professor’s Conference in Atlanta, GA in 2017. On a panel together, we each presented on topics relating to product hopping, but from very different perspectives. Glenn Cohen’s Health Law Policy, Bioethics, and Biotechnology Workshop at HLS.
Bill of Health
NOVEMBER 3, 2023
PROM responses can be used for purposes of clinical care, research, quality improvement, Food and Drug Administration (FDA) approval of drugs and devices, and even insurance reimbursement. Health Pol’y, Law, and Ethics 1 (2023). The post Key Considerations for Patient-Reported Outcome Measures first appeared on Bill of Health.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Health Populi
AUGUST 12, 2021
In health care, outdated operating systems present some of the greatest risks: 15% of medical devices and 32% of medical imaging tools run on outdated operating systems. “During the chaos and confusion, threat actors launched cyberattacks,” Ordr observed in the wake of the public health crisis.
Health Populi
JANUARY 18, 2021
CES 2021 featured some obvious quick-pivoting products that had the pandemic written all over them, with sessions invariably speaking to the way the public health crisis impacted companies and strategic plans. During the pandemic, inpatient hospital beds have been in short supply in various communities across the U.S.,
Bill of Health
JANUARY 7, 2022
Over the summer of 2021, concern grew that the vaccines were not providing the near-perfect protection against symptomatic disease and transmission that had first emboldened the administration to jettison other public health measures. Ultimately, both the FDA and CDC gave their blessing to boosters.
Expert insights. Personalized for you.
313 
Let's personalize your content